EUVIMEDOpdag EUVIMED
Crossref

Novel Metabolic‐Prognostic Integration Reveals TCF21‐Mediated Mitochondrial Regulation in Endometrial Cancer

Ciren Guo, Jianfeng Zheng, Xuefen Lin, Xiafei Ye, Xinyan Jiang, Yang Sun iD

Molecular Carcinogenesis · 2025

DOI: 10.1002/mc.70041 ↗

At a glance

Journal article in Molecular Carcinogenesis, 2025. Written by Ciren Guo and 5 co-authors. Institution: Department of Gynecology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China. Major MEDLINE topics: Endometrial Neoplasms, Mitochondria, Biomarkers, Tumor, Basic Helix-Loop-Helix Proteins. Cited 1 times so far (Crossref); 83 references. Funded by: This project was funded by grant from Clinical Research Center for Precision Treatment of Gynecological Malignancies of Fujian Province, China (Grant number: 2….

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Despite endometrial cancer (EC) being a malignancy linked to metabolic disorders such as diabetes and obesity, its prognostic markers and metabolic dysregulation remain incompletely understood. Gene expression profiles and clinical data were obtained from TCGA. Metabolism‐regulating genes (MRGs) were identified by intersecting genes linked to diabetes, obesity, and EC prognosis. A prognostic MRG‐model was developed using LASSO Cox regression. Functional pathway features of the MRG‐model were analyzed for prognostic signals, immune status, and antitumor therapy using methods such as gene set enrichment analysis, GSVA, ssGSEA, EPIC, CIBERSORT, and others. Machine learning algorithms identified the optimal MRG, TCF21, for in vivo and in vitro validation through experiments including colony formation, CCK8 assays, wound healing, Transwell assays, measurement of reactive oxygen species and ATP levels. We identified 72 candidate genes related to EC metabolism and progression. The MRG‐model effectively distinguished high‐risk from low‐risk EC patients and demonstrated strong prognostic predictive capacity. Significant differences were observed between the two groups in clinical factors, functional pathways, immune characteristics, mutation profiles, and treatment recommendations. TCF21, with optimal performance, was selected for further study. TCF21 expression was significantly downregulated in EC and correlated with DNA methylation. As a tumor suppressor, TCF21 regulates proliferation, migration, invasion, and mitochondrial metabolism in EC via PDE2A. The MRG‐model can serve as a robust tool for prognostic prediction and support personalized EC treatment, enhancing its clinical potential. TCF21 is methylated in EC, and its regulation of PDE2A governs the malignant phenotype and mitochondrial metabolism.

Subjects

MeSH terms (MEDLINE)

Endometrial NeoplasmsMitochondriaBiomarkers, TumorBasic Helix-Loop-Helix ProteinsHumansFemalePrognosisGene Expression Regulation, NeoplasticAnimalsMiceCell ProliferationDNA MethylationCell Line, TumorCell MovementGene Expression Profiling

Author keywords

TCF21endometrial cancermetabolismrisk model

Substances

Biomarkers, TumorBasic Helix-Loop-Helix ProteinsTCF21 protein, human

Authors and institutions

  • Department of Gynecology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.
  • Fujian Provincial Key Laboratory of Tumor Biotherapy, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.

ORCID profiles: Yang Sun

Funding

  • This project was funded by grant from Clinical Research Center for Precision Treatment of Gynecological Malignancies of Fujian Province, China (Grant number: 2…

Cite

APA

Guo, C., Zheng, J., Lin, X., Ye, X., Jiang, X., & Sun, Y. (2025). Novel Metabolic‐Prognostic Integration Reveals TCF21‐Mediated Mitochondrial Regulation in Endometrial Cancer. Molecular Carcinogenesis. https://doi.org/10.1002/mc.70041

Vancouver

Guo C, Zheng J, Lin X, Ye X, Jiang X, Sun Y. Novel Metabolic‐Prognostic Integration Reveals TCF21‐Mediated Mitochondrial Regulation in Endometrial Cancer. Molecular Carcinogenesis. 2025. doi:10.1002/mc.70041

BibTeX
@article{Guo2025,
  author = {Guo, Ciren and Zheng, Jianfeng and Lin, Xuefen and Ye, Xiafei and Jiang, Xinyan and Sun, Yang},
  title = {Novel Metabolic‐Prognostic Integration Reveals TCF21‐Mediated Mitochondrial Regulation in Endometrial Cancer},
  journal = {Molecular Carcinogenesis},
  year = {2025},
  doi = {10.1002/mc.70041}
}
Start for free →